日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Methylated PIH1D1 as a Heart-Specific Biomarker for Anthracycline-Induced Cardiac Remodeling in Breast Cancer Patients

甲基化的PIH1D1作为蒽环类药物诱导乳腺癌患者心脏重塑的心脏特异性生物标志物

期刊:Jacc-Basic To Translational Science
影响因子:7.2
doi:10.1016/j.jacbts.2026.101510
Hsu, Po-Yen; Huang, Wan-Hong; Lee, Yi-Yun; Passier, Robert; Li, Szu-Chin; Hong, Chong-Lin; Hung, Shih-Kai; Lin, Hong-Yi; Lin, Chun-Hung; Chien, Chen-Yu; Li, Yi-Da; Lee, Hsiang-Chun; Désaubry, Laurent; Nebigil, Canan G; Chan, Michael W Y
肿瘤
表观遗传
乳腺癌
肿瘤免疫
发表日期：2026
文献求助 收藏

Promotion of cardiac microtissue assembly within G-CSF-enriched collagen I-cardiogel hybrid hydrogel

促进富含 G-CSF 的胶原蛋白 I-心脏凝胶混合水凝胶中的心脏微组织组装

期刊:Regenerative Biomaterials
影响因子:5.6
doi:10.1093/rb/rbae072
Hamid Khodayari, Saeed Khodayari, Malihe Rezaee, Siamak Rezaeiani, Mahmoud Alipour Choshali, Saiedeh Erfanian, Ahad Muhammadnejad, Fatemeh Nili, Yasaman Pourmehran, Reihaneh Pirjani, Sarah Rajabi, Naser Aghdami, Canan Nebigil-Désaubry, Kai Wang, Habibollah Mahmoodzadeh, Sara Pahlavan
信号转导
发表日期：2024
文献求助 收藏

The flavagline FL3 interferes with the association of Annexin A2 with the eIF4F initiation complex and transiently stimulates the translation of annexin A2 mRNA

黄连素 FL3 可干扰 Annexin A2 与 eIF4F 起始复合物的结合，并暂时刺激 Annexin A2 mRNA 的翻译

期刊:Frontiers in Cell and Developmental Biology
影响因子:4.6
doi:10.3389/fcell.2023.1094941
Ann Kari Grindheim, Sudarshan S Patil, Canan G Nebigil, Laurent Désaubry, Anni Vedeler
信号转导
WB
发表日期：2023
文献求助 收藏

Editorial: HF2Cancer: Exploring bidirectional interaction between cardiovascular diseases and cancer

社论：HF2Cancer：探索心血管疾病与癌症之间的双向相互作用

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2023.1145780
Nebigil, Canan G; Chan, Michael W Y
心血管疾病
肿瘤
心血管
肿瘤免疫
发表日期：2023
文献求助 收藏

Therapeutic Potential of Targeting Prokineticin Receptors in Diseases

靶向促动力素受体治疗疾病的潜力

期刊:Pharmacological Reviews
影响因子:
doi:10.1124/pharmrev.122.000801
Vincenzi, Martina; Kremić, Amin; Jouve, Appoline; Lattanzi, Roberta; Miele, Rossella; Benharouga, Mohamed; Alfaidy, Nadia; Migrenne-Li, Stephanie; Kanthasamy, Anumantha G; Porcionatto, Marimelia; Ferrara, Napoleone; Tetko, Igor V; Désaubry, Laurent; Nebigil, Canan G
信号转导
发表日期：2023
文献求助 收藏

Evidence for reciprocal network interactions between injured hearts and cancer

受损心脏与癌症之间互惠网络相互作用的证据

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2022.929259
Guler, Melisa N; Tscheiller, Nathalie M; Sabater-Molina, Maria; Gimeno, Juan R; Nebigil, Canan G
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies

压力超负荷介导的心肌细胞持续 PKR2（促动力素-2 受体）信号传导导致心脏肥大和内皮病

期刊:Hypertension
影响因子:6.9
doi:10.1161/HYPERTENSIONAHA.120.16808
Ferda Demir, Kyoji Urayama, Anais Audebrand, Ayca Toprak-Semiz, Marja Steenman, Hitoshi Kurose, Canan G Nebigil
细胞生物学
其它细胞
发表日期：2021
文献求助 收藏

Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies

抗癌治疗介导的血管毒性研究进展及治疗策略新方向

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2021.694711
Hsu, Po-Yen; Mammadova, Aynura; Benkirane-Jessel, Nadia; Désaubry, Laurent; Nebigil, Canan G
肿瘤
毒理研究
肿瘤免疫
发表日期：2021
文献求助 收藏

Prohibitin ligands: a growing armamentarium to tackle cancers, osteoporosis, inflammatory, cardiac and neurological diseases

抑制性配体：对抗癌症、骨质疏松症、炎症、心脏病和神经系统疾病的日益强大的武器库

期刊:Cellular and Molecular Life Sciences
影响因子:6.2
doi:10.1007/s00018-020-03475-1
Wang, Dong; Tabti, Redouane; Elderwish, Sabria; Abou-Hamdan, Hussein; Djehal, Amel; Yu, Peng; Yurugi, Hajime; Rajalingam, Krishnaraj; Nebigil, Canan G; Désaubry, Laurent
肿瘤
炎症
肿瘤免疫
炎症/感染
心血管
代谢
骨质疏松
心脏病
发表日期：2020
文献求助 收藏

Editorial: Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-Oncology: From Bench to Bedside

社论：心血管肿瘤学中心血管和代谢功能障碍的新挑战：从实验室到临床

期刊:Frontiers in Cardiovascular Medicine
影响因子:2.9
doi:10.3389/fcvm.2020.00148
Nebigil, Canan G; Chan, Michael W Y; Rassaf, Tienush
肿瘤
肿瘤免疫
代谢
发表日期：2020
文献求助 收藏